Search results for "summary"

showing 10 items of 47 documents

Lessons from the 2018-2019 European droughts : a collective need for unifying drought risk management

2022

Funding Information: This open-access publication was funded by the University of Freiburg. Funding Information: Financial support. The project is supported by the Wassernetzwerk Baden-Württemberg (Water Research Network of the State Baden-Württemberg), which is funded by the Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (Ministry of Science, Research and the Arts of the State Baden-Württemberg) (grant no. AZ. 7532.21/2.1.6) and Maa-ja vesitekniikan tuki ry foundation. Doris E. Wendt acknowledges her support as part of the NERC-funded Groundwater Drought Initiative (NE/R004994/1). Lucy J. Barker was supported by the Natural Environment Research Council (NE/R016429/1) a…

IMPACTSdrought ; risk ; management ; strategy ; stakeholders ; EuropeHidrologíamedia_common.quotation_subjectWATER-RESOURCESCIRCULATIONVulnerabilityEarth and Planetary Sciences(all)Oceanografi hydrologi och vattenresurserMETEOROLOGICAL DROUGHT/dk/atira/pure/sustainabledevelopmentgoals/clean_water_and_sanitationEVENTSOceanography Hydrology and Water ResourcesShort summary: Recent drought events caused enormous damage in Europe. We therefore questioned the existence and effect of current drought management strategies on the actual impacts and how drought is perceived by relevant stakeholders. Over 700 participants from 28 European countries provided insights into drought hazard and impact perception and current management strategies. The study concludes with an urgent need to collectively combat drought risk via a European macro-level drought governance approach.11. SustainabilityMeteorology & Atmospheric SciencesLife ScienceGeosciences MultidisciplinaryEnvironmental planningmedia_commonScience & TechnologyWIMEKCorporate governanceGeologyDirectiveHazard6. Clean waterWater Resources ManagementWater resourcesGeographyHarm13. Climate actionPhysical SciencesWater ResourcesGeneral Earth and Planetary SciencesWater Systems and Global ChangePsychological resilienceHydrologySDG 6 - Clean Water and SanitationDiversity (business)Natural Hazards and Earth System Sciences
researchProduct

Interpretation and Chemometric Evaluation of the Bilirubin Interference in the Kinetic Spectrophotometry Determination of Creatinine in Serum by Use …

1992

Abstract SUMMARY In an alkaline picrate medium we demonstrated the occurrence of isosbestic points over the range 520–550 nm, the position depending on the bilirubin content and less on the albumin content. Bilirubin does not markedly modify the ratt constant of the reaction between creatinine and picrate, however, it does modify the intercept of the Ln ΔA vs t, plots. The absolute value of Ln ΔA varies with the concentration, though not with time, which indicates that bilirubin acts by consuming part of the initially present creatinine irrespective of its owr concentration at the wavelengths typically used in the creatinine determination. The Ln ΔA values at the isosbestic points coincide …

Isosbestic pointCreatininemedicine.diagnostic_testBilirubinPicrateBiochemistry (medical)Clinical BiochemistryAnalytical chemistryAlbuminKinetic energyBiochemistryAnalytical Chemistrychemistry.chemical_compoundchemistrySpectrophotometryElectrochemistrymedicineAbstract SummarySpectroscopyAnalytical Letters
researchProduct

HL7v3 CDA Rel.2 prescription: Localization experience and GP Integration Project

2010

The localization experience for the e-prescription, based on the Health Level Seven Version 3 (HL7v3) Clinical Document Architecture, Release 2 (CDA Rel.2), is presented. As application, we propose a project of General Practitioners Integration with the EHR (Electronic Health Record), implementing the e-prescription, patient summary and other CDA Rel.2 documents. The integration is made possible with HL7v3, the most widely used standard for healthcare information interoperability. The project is in line with the state of the art in the normative referring context for the Italian Healthcare, both at national and regional level (Tuscany Region). Final remarks are drawn, also referring to the …

Knowledge managementbusiness.industrycomputer.internet_protocolContext (language use)computer.file_formatInteroperabilityClinical Document ArchitectureInteroperability; e-Health; Localization; Hl7v3Interoperability e-Health Localization Hl7v3Hl7v3Settore ING-INF/04 - AutomaticaLocalizationHealth caree-HealtheHealthNormativeMedicineMedical prescriptionPatient summarybusinesscomputerXML2010 IEEE Workshop on Health Care Management (WHCM)
researchProduct

How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016

2020

Purpose. To describe intravitreal anti-VEGF drug and dexamethasone use in four Italian regions. Methods. Four regional claims databases were used to measure drug prevalence, compare dosing intervals to those recommended in the summary of product characteristics (SPC), and identify switchers. Bilateral treatment and diabetic macular edema (DME) coding algorithms were validated, linking claims with a sample of prospectively collected ophthalmological data. Results. Overall, 41,836 patients received ≥1 study drug in 2010–2016 (4.8 per 10,000 persons). In 2016, anti-VEGF drug use ranged from 0.8 (Basilicata) to 5.7 (Lombardy) per 10,000 persons while intravitreal dexamethasone use ranged from 0…

MaleVascular Endothelial Growth Factor A0301 basic medicineintravitrealAngiogenesis Inhibitorsalgorithm.0302 clinical medicineMedicineSummary of Product Characteristicsmedia_commonAged 80 and overDrug ImplantsvalidationLaser CoagulationRGeneral MedicineMiddle AgedItalyanti-VEGF030220 oncology & carcinogenesisMedicineFemaleclinical dataoriginal articleResearch Articlemedicine.drugDrugmedicine.medical_specialtyArticle Subjectmedia_common.quotation_subjectMEDLINEdexamethasonePharmacyMacular EdemaGeneral Biochemistry Genetics and Molecular BiologyInsurance Claim Review03 medical and health sciencesRanibizumabInternal medicineHumansDosingDexamethasoneAgedDiabetic RetinopathyGeneral Immunology and MicrobiologySettore MED/30 - Malattie Apparato Visivobusiness.industryclaims database030104 developmental biologydrug utilisationMacular Edema; Ranibizumab; Laser CoagulationImplantRanibizumabbusinessBioMed Research International
researchProduct

Hydrological post-processing based on approximate Bayesian computation (ABC)

2019

[EN] This study introduces a method to quantify the conditional predictive uncertainty in hydrological post-processing contexts when it is cumbersome to calculate the likelihood (intractable likelihood). Sometimes, it can be difficult to calculate the likelihood itself in hydrological modelling, specially working with complex models or with ungauged catchments. Therefore, we propose the ABC post-processor that exchanges the requirement of calculating the likelihood function by the use of some sufficient summary statistics and synthetic datasets. The aim is to show that the conditional predictive distribution is qualitatively similar produced by the exact predictive (MCMC post-processor) or …

Mathematical optimizationINGENIERIA HIDRAULICAEnvironmental Engineering010504 meteorology & atmospheric sciencesComputer scienceHydrological modelling0208 environmental biotechnologyComputational intelligence02 engineering and technologySummary statistic01 natural sciencesFree-likelihood approachsymbols.namesakeHydrological forecastingEnvironmental ChemistryProbabilistic modellingSafety Risk Reliability and QualityUncertainty analysis0105 earth and related environmental sciencesGeneral Environmental ScienceWater Science and TechnologyProbabilistic modellingMarkov chain Monte Carlo020801 environmental engineeringBenchmark (computing)symbolsUncertainty analysisApproximate Bayesian computationSummary statisticsLikelihood functionSettore SECS-S/01 - Statistica
researchProduct

Executive summary of EPOS 2020 including integrated care pathways.

2020

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012 (1-3). The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become…

Medical educationExecutive summaryEvidence-based practicebusiness.industryOutcome measurementsDelivery of Health Care IntegratedMEDLINEGeneral MedicineGuidelineSinus surgery3. Good healthIntegrated care03 medical and health sciences0302 clinical medicineNasal PolypsOtorhinolaryngologyChronic DiseaseMedicinePosition paperHumansSinusitis030223 otorhinolaryngologybusinessRhinitisRhinology
researchProduct

A Systematic Review of the Use of Social Media for Dissemination of Clinical Practice Guidelines

2021

Item does not contain fulltext CONTEXT: Clinical practice guideline (CPG) uptake does not occur spontaneously and requires active implementation, especially for long-term implementation. Social media (SoMe) with its power of rapid and global information exchange among physicians, patients, organizations, and stakeholders in the medical field can open up unprecedented opportunities for CPG dissemination. OBJECTIVE: The aim of this review was to assess the current use of SoMe in CPG dissemination across different medical specialties. EVIDENCE ACQUISITION: A systematic review (SR) of the literature was conducted using Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) …

Medical educationbusiness.industryUrologyHealth Personnel030232 urology & nephrologyMEDLINEContext (language use)GuidelineClinical Practice03 medical and health sciences0302 clinical medicineSystematic reviewResearch Design030220 oncology & carcinogenesisUrological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15]MedicineHumansSocial mediaPatient summarybusinessSocial MediaEvidence synthesis
researchProduct

La responsabilità della capogruppo per la violazione del duty of care: note a margine di Okpabi v. Royal Dutch Shell Plc

2021

The paper examines a UK-Supreme Court of Justice decision (Okbapi v. Royal Dutch Shell Plc) concerning the liability of a parent company for the abusive con-ducts of its subsidiaries. The Court explores whether and in what circumstances the UK-domiciled parent company of a multi-national group of companies may owe a common law duty of care to individuals who allegedly suffer serious harm as a re-sult of alleged systemic health, safety and environmental failings of one of its overseas subsidiaries as the operator of a joint venture operation. Although the decision focuses on preliminary issues of summary judgment, it pro-vides inputs to a renewed reflection on the duty of care upon the paren…

Multinational groups Parental liability Duty of care Summary judgment
researchProduct

French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs

2010

The prescription information (summary of product characteristics, SPC) is compiled by the pharmaceutical industry as required by the national regulatory authorities. They vary in their content about the properties of drugs and about the usefulness of therapeutic drug monitoring (TDM) in the blood of patients. Based on a previous study carried out in Germany, the degree of agreement of French SPC for 59 psychotropic drugs with the existing medico-scientific evidence in the area of TDM was examined using a recently developed instrument. A summary score of SPC content (SPCC) related to TDM (SPCC TDM ) has been calculated and compared with the level of recommendation of TDM of the AGNP-TDM expe…

PharmacologyDrugmedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectProduct characteristicsNeuropsychopharmacologyMoodTherapeutic drug monitoringmedicinePharmacology (medical)Summary of Product CharacteristicsMedical prescriptionPsychiatrybusinessmedia_commonPharmaceutical industryFundamental & Clinical Pharmacology
researchProduct

“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical S…

2011

PharmacologyExecutive summaryLife styleStatement (logic)business.industryMEDLINEBioinformaticsPathophysiologychemistry.chemical_compoundchemistryLow-density lipoproteinMedicineClinical significanceCardiology and Cardiovascular MedicinebusinessCurrent Vascular Pharmacology
researchProduct